HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury.

AbstractBACKGROUND:
Apoptosis of hepatocytes contributes to many forms of liver pathology and can compromise liver function. Hepatocytes have been shown to require mitochondrial disruption to execute apoptosis, a process that is controlled by members of the Bcl-2 family. Bid is a proapoptotic Bcl-2 family member that is cleaved to its active form, tBid, by caspase 8 and granzyme B. Studies in the Bid-deficient mouse have established that hepatocytes require Bid to undergo apoptosis.
METHODS:
We generated aspartic acid to glutamic acid mutations in the rat Bid protein, at the caspase 8 and granzyme B cleavage sites, and utilized recombinant adenoviruses to express this protein in hepatoma cells and in the livers of rats.
RESULTS:
Cells transduced with recombinant adenoviruses encoding Bid containing mutations to the caspase 8 and granzyme B cleavage sites are significantly protected from both tumor necrosis factor-alpha-induced and cell-mediated apoptosis. Protection occurs through a mechanism that includes decreased Bid cleavage, caspase activation, and mitochondrial membrane damage. Further, after warm ischemia/reperfusion injury, we show that rats expressing cleavage-resistant Bid in the liver display significantly less hepatocyte apoptosis as compared to control rat livers and this results in improved liver function and survival.
CONCLUSION:
Our results suggest that reagents that prevent the cleavage of Bid would be an effective strategy to inhibit hepatocyte apoptosis and decrease liver injury.
AuthorsErica Riddle-Taylor, Kazuhito Nagasaki, Joseph Lopez, Carlos O Esquivel, Olivia M Martinez, Sheri M Krams
JournalTransplantation (Transplantation) Vol. 84 Issue 6 Pg. 778-85 (Sep 27 2007) ISSN: 0041-1337 [Print] United States
PMID17893612 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • BH3 Interacting Domain Death Agonist Protein
  • Bid protein, rat
  • Aspartic Acid
  • Glutamic Acid
  • Granzymes
  • Caspase 8
Topics
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Animals
  • Apoptosis (genetics)
  • Aspartic Acid (chemistry, genetics)
  • BH3 Interacting Domain Death Agonist Protein (genetics, metabolism)
  • Caspase 8 (metabolism)
  • Glutamic Acid (chemistry, genetics)
  • Granzymes (metabolism)
  • Hepatocytes (metabolism, pathology)
  • Molecular Sequence Data
  • Mutation
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (genetics, pathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: